Medical Devices

Haemonetics

$114.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$5.07 (-4.26%) Today
$0.00 (0.00%) As of 12:33 PM UTC after-hours

Why Robinhood?

You can buy or sell Haemonetics and other stocks, options, and ETFs commission-free!

About HAE

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following business segments: Plasma, Blood Center and Hospital. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment offers a range of solutions that improve donor collection centers' ability to acquire blood, filter blood and separate blood components. The Hospital segment provides heomostasis management, cell salvage and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Braintree, MA. The listed name for HAE is Haemonetics Corporation.

CEO
Christopher A. Simon
Employees
3,004
Headquarters
Boston, Massachusetts
Founded
1971
Market Cap
5.99B
Price-Earnings Ratio
57.56
Dividend Yield
Average Volume
536.00K
High Today
$116.17
Low Today
$112.41
Open Price
$115.44
Volume
621.04K
52 Week High
$129.92
52 Week Low
$63.41

Collections

HAE Earnings

$0.00
$0.31
$0.63
$0.94
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
per share
Actual
Available Feb 2, Pre-Market

You May Also Like

LINX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure